Dr. Hirshberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
419 Greenebaum Ln
Gaithersburg, MD 20878
Education & Training
- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1994
Publications & Presentations
PubMed
- 4 citationsLEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Sta...Christian T. Ruff, Michael J. Koren, Joseph Grimsby, Anton I. Rosenbaum, Xiao Tu
Arteriosclerosis, Thrombosis, and Vascular Biology. 2021-10-28 - 165 citationsEffects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study.Rajaa Nahra, Tao Wang, Kishore M. Gadde, Jan Oscarsson, Michael Stumvoll
Diabetes Care. 2021-05-20 - 15 citationsBlocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial.John E. Le Lay, Qun Du, Minal B. Mehta, Nicholas Bhagroo, B. Timothy Hummer
Science Translational Medicine. 2021-04-21
Press Mentions
- Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid ProductsDecember 1st, 2020
- Regeneron Present Long-Term Efficacy and Safety Data for Eylea HD for Wet AMD and DME at AAO 2023November 3rd, 2023
- Regeneron Announces Several Eylea HD (Aflibercept 8 Mg) Presentations at ARVOApril 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: